Skip to main content
OpenTrials
Completed

NCT Number: NCT03681366

Myopia Control Using Optimized Optical Defocus RCTs

The aims of the study is to evaluate whether the DISC3.5 Plus contact lens will slow myopia progression and axial length growth in myopic children as compared with single vision soft contact lenses.

Completed

Looking for future studies?

Notify Me

Key information

Age range

8 year–13 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Centre of Myopia Ressearch, School of Optometry, The Hong Kong PolyU

Hong Kong, China

About this study

The purpose of the current study is to evaluate whether the DISC3.5 Plus contact lens will slow myopia progression and axial length growth in myopic children as compared with single vision soft contact lenses.

The Defocus Incorporated Soft 3.5 Plus Contact Lens (DISC3.5 Plus) is a soft contact lens that comprises of simultaneous distance optical prescription and myopic defocus areas.

The efficacy of the DISC3.5 Plus lens in slowing myopia progression (change in refractive error) will be compared to a spherical (front and back surface) single vision soft contact lenses in this one-year prospective, randomised and double-masked clinical trial. The hypothesis of this study is that the DISC3.5 Plus will slow myopia progression more than spherical single vision soft contact lenses.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age at enrolment: 8-13 year; Hong Kong Chinese
  • Spherical equivalent refractions (SER): -1.00 to -5.00D
  • Astigmatism: -1.00D or less
  • Anisometropia: 1.25D or less
  • Spectacle corrected monocular visual acuity (VA): 0.0 logMAR or better
  • Contact lens corrected monocular VA: 0.1 logMAR or better
  • Normal binocular function
  • Willingness to wear contact lenses regularly
  • Parents' understanding and acceptance of random allocation of grouping and masking

Exclusion criteria

  • Prior myopia control treatment, e.g. orthokeratology, defocus soft contact lenses, progressive addition lenses, bifocal lenses, drugs (e.g. atropine), etc.
  • Strabismus or decompensated phoria (checked by cover test at far and near in screening)
  • Known contraindications for contact lens wear
  • Have any ocular and systemic diseases and abnormalities that might affect visual function or refractive development

Treatment and study plan

DISC3.5 plus

Device

The Defocus Incorporated Soft 3.5 Plus Contact Lens (DISC3.5 Plus) is a soft contact lens that comprises of simultaneous distance optical prescription and myopic defocus areas.

Primary outcomes

  1. Cycloplegic Refraction Change in SER

    Time frame: 12 months

    Change in cycloplegic autorefraction in spherical equivalent (SER)

Secondary outcomes

  1. Axial length

    Time frame: 12 months

    Axial length (mm) was measured after cycloplegia

Sponsors and collaborators

Lead sponsor

The Hong Kong Polytechnic University

Other

Registry information

Official study title

Myopia Control Using Optimized Optical Defocus in Schoolchildren - a Randomized Double Masked Control Trial

Important dates

Study start
2018
Primary completion
2021
Study completion
2022
First posted
Sep 24, 2018
Registry last updated
Aug 24, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.